Industry, FDA Agree On Draft User Fee Commitment Letter

Draft commitment and legislative language come one month after agreement “in principle” on MDUFA III reauthorization.

FDA and industry have agreed to a draft commitment letter and proposed legislative language to reauthorize device-related FDA user fees.

The commitment, detailed in documents released by FDA last week, comes one month after the parties reached an agreement “in...

More from Regulation

More from Policy & Regulation